Fig. 2
From: Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
a Based on the TCGA dataset, the expression levels of CBX3 were analyzed by the main pathological stages (stage I, stage II, stage III, and stage IV) of ACC, KICH, OV, LIHC, THCA, and TGCT. Log2 (TPM + 1) was applied for log-scale. b Based on the CPTAC dataset, we analyzed the expression level of CBX3 total protein between normal tissue and primary tissue of breast cancer, colon cancer, ovarian cancer, clear cell RCC, LUAD, and UCEC. ***P < 0.001. c We showed representative and contrastive immunohistochemistry images of CBX3 in tumor tissues and normal tissues